All News
National Population Insights (4.28.2023)
Dr. Jack Cush reviews the news and journal reports and addresses 3 viewer case questions.
Read Article
Romania to U.S.: My Journey to a Permanent Residency
One in four practicing physicians in the United States are international medical graduates. I am one of them. Here is what I learned, and my advice to others who are on a similar journey.
Read Article
25 Great Women in Rheumatology
This week I reached out to many leaders in rheumatology and asked: who are the great women in rheumatology who should be recognized? This was prompted by a smart article in Annals of Rheumatic Disease written by Drs. Tuhina Neogi (Boston) and Nicola Dalbeth (N. Zealand), entitled "Where are the women ‘Heroes and Pillars of Rheumatology’?
Read Article
Join us this Tuesday for our the start of our May Tuesday Night Rheumatology focusing on Rheumatoid Arthritis: Revolutionary Advances in Therapy
https://t.co/TbNYaGJ3sk https://t.co/DiJwjvUX1d
Links:
Dr. John Cush RheumNow ( View Tweet)
RheumThoughts: No is a complete sentence
Dr. Rachel Tate ( @uptoTate ) shares her POV.
https://t.co/0xzTobgmIQ https://t.co/YvEUMsqLyV
Links:
Dr. John Cush RheumNow ( View Tweet)
25 Great Women in Rheumatology
This week I reached out to many leaders in rheumatology and asked: who are the great women in rheumatology who should be recognized?
I'm sharing the responses.
https://t.co/N1zqs3TJuv https://t.co/LXDxnXUaG9
Links:
Dr. John Cush RheumNow ( View Tweet)
Denosumab Reduces Type II Diabetes Risk
The British Medical Journal has published a matched cohort analysis demonstrating that adults receiving denosumab had a lower risk of NIDDM compared with those taking oral bisphosphonates for osteoporosis.
https://t.co/7SMjp258gX https://t.co/SAUmahwV9J
Links:
Dr. John Cush RheumNow ( View Tweet)
How Being a Patient Taught Me to Be a Better Doctor
Dr. Marcella Ferrada ( @maferradastrong ) shares her experience having a rare disease and how it positively impacted her skills as a physician.
https://t.co/eUHzPTjRv8 https://t.co/rTIfyLwVLY
Links:
Dr. John Cush RheumNow ( View Tweet)
A Danish national registry study compared RA pts taking JAKi (n 875) and bDMARDs (n 4247). They found similar rates of subsequent cancers (14.4 vs 12.9/ per 1000 PYRS); with a nonsignificant risk (HR1.41; CI 0.76, 2.37) https://t.co/wfrlAcij8x https://t.co/OvqKrHw5Wu
Links:
Dr. John Cush RheumNow ( View Tweet)
RheumThoughts: No is a complete sentence
Dr. Rachel Tate ( @uptoTate ) shares her POV.
https://t.co/TGcFuGl4Lp https://t.co/N0bItVkHjM
Links:
Dr. John Cush RheumNow ( View Tweet)
25 Great Women in Rheumatology
This week I reached out to many leaders in rheumatology and asked: who are the great women in rheumatology who should be recognized?
I'm sharing the responses.
https://t.co/0d7SkgpcN5 https://t.co/nQVfs5oMFL
Links:
Dr. John Cush RheumNow ( View Tweet)
Narrative Medicine
Dr. Aviya Lanis shares with us how narrative medicine helped her become a more engaging doctor.
https://t.co/YJdsa50FBF https://t.co/7D3DiBnqaK
Links:
Dr. John Cush RheumNow ( View Tweet)
Metanalysis of Steroids in hosp community-acquired pneumonia (CAP). 18 studies 4661 pts. Corticosteroids reduced mortality in more severe CAP (RR 0.62; 0.45 to 0.85), but not less severe CAP(RR 1.08). Steroids lower need for mech ventilation, ICU https://t.co/dj7zABqQ3r https://t.co/Mb4g7ICdX9
Links:
Dr. John Cush RheumNow ( View Tweet)
Metanalysis of IV NA Thiosulphate for Calciphylaxis in CKD shows NO improvement in skin lesion (RR 1.23; 0.85-1.78) or survival (HR 0.82; 0.57-1.18); based on 19 studies and 422 pts https://t.co/0uyHhWJpFJ https://t.co/dkRgRjh2cH
Links:
Dr. John Cush RheumNow ( View Tweet)
Analysis of 14,958 RA pts in Japans National Database of Rheumatic Diseases (NinJa) shows women had higher DAS28-ESR values than males, despite no obvious difference in other indices or disease activity categories. https://t.co/PYsTGnejOF https://t.co/AqOiiZm3uI
Links:
Dr. John Cush RheumNow ( View Tweet)
NIH generated FDA approved drug costs ~$1.4-1.7 billlion for each 1st-in-class drug (vs estimated pharma industry cost of $1.5 billion per approved Rx). Govt may serve as early investor in pharma innovations. ~1/2 total R&D investment comes from US govt https://t.co/PORuiowRBy? https://t.co/urPkqX98A6
Links:
Dr. John Cush RheumNow ( View Tweet)
Prospective study.of 370 #FM pts (79% F; age 34yrs), and 79% were female w/ 14.3 tender points. A delay in Dx was signif correlated wtih Sx Severity Scale (r = 0.14) & tender points (r = 0.16), but not widespread pain. Early Dx = less severe FM. https://t.co/tvl0rkREHe https://t.co/OduJ3cq4Jg
Links:
Dr. John Cush RheumNow ( View Tweet)
Aging Mechanisms Tied to Giant Cell Arteritis
Senescence pathways are involved in GCA, an analysis of patient tissue samples suggested, which may account for the efficacy of one agent now used for the disease and another in commercial development.
https://t.co/nPSidkCvDk https://t.co/FNbbSPpZVS
Links:
Dr. John Cush RheumNow ( View Tweet)
A Rising Gout Risk in Asians
Two independent data sets suggests the prevalence of gout among Asians has grown such that this sub-population has numerically surpassed all other racial and ethnic groups by 2018.
https://t.co/aKMLIzRTTh https://t.co/8ZpKNnIady
Links:
Dr. John Cush RheumNow ( View Tweet)
How Being a Patient Taught Me to Be a Better Doctor
Dr. Marcella Ferrada ( @maferradastrong ) shares her experience having a rare disease and how it positively impacted her skills as a physician.
https://t.co/MUJQTHT681 https://t.co/nzQ3st2fTT
Links:
Dr. John Cush RheumNow ( View Tweet)